Subscribe to RSS
DOI: 10.1055/s-0028-1083502
Synthesis of Cyclic Sulfonamides via Pd-Catalyzed Intramolecular Coupling Reaction: An Expedient Approach to Polycyclic Sultams
Publication History
Publication Date:
15 October 2008 (online)

Abstract
A divergent synthetic approach to polycyclic sultams utilizing intramolecular ligand-free intramolecular coupling reaction is described.
Key words
sulfonamide drugs - sultams - ligand-free cross-coupling reaction - palladium acetate
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Drews J. Science 2000, 287: 1960 -
1b
Scozzafava A.Owa T.Mastrolorenzo A.Supuran CT. Curr. Med. Chem. 2003, 10: 925 -
2a
Gennari C.Salom B.Potenza D.Williams A. Angew. Chem., Int. Ed. Engl. 1994, 33: 2067 -
2b
Moree WJ.van der Marel GA.Liskamp RMJ. J. Org. Chem. 1995, 60: 5157 -
2c
Gennari C.Nestler HP.Salom B.Still WC. Angew. Chem., Int. Ed. Engl. 1995, 34: 1765 -
2d
Roush WR.Gwaltney SL.Cheng J.Scheidt KA.McKerrow JH.Hansell E. J. Am. Chem. Soc. 1998, 120: 10994 -
3a
Ghosh AK.Kincaid JF.Cho W.Walters DE.Krishnan K.Hussain KA.Koo Y.Cho H.Rudall C.Holland L.Buthod J. Bioorg. Med. Chem. Lett. 1998, 8: 687 -
3b
Radkiewicz JL.McAllister MA.Goldstein E.Houk KN. J. Org. Chem. 1998, 63: 1419 -
4a
Kim SW.Hong CY.Lee EJ.Koh JS. Bioorg. Med. Chem. Lett. 1998, 8: 735 -
4b
Jones-Hertzog DK.Jorgensen WL. J. Med. Chem. 1997, 40: 1539 - 5
Brashear KM.Cook JJ.Bednar B.Bednar RA.Gould RJ.Halczenko W.Holahan MA.Lynch RJ.Hartman GD.Hutchinson JH. Bioorg. Med. Chem. Lett. 1997, 7: 2793 - 6
Bradbury RH.Bath C.Butlin RJ.Dennis M.Heys C.Hunt SJ.James R.Mortlock AA.Summer NF.Tang EK.Telford B.Whiting E.Wilson C. J. Med. Chem. 1997, 40: 996 - 7
Hanessian S.Sailes H.Therrien E. Tetrahedron 2003, 59: 7047 -
8a
Silvestri R.Marfe G.Artico M.La Regina G.Lavecchia A.Novellino E.Morgante M.Di Stefano C.Catalano G.Filomeni G.Abruzzese E.Ciriolo MR.Russo MA.Amadori S.Cirilli R.La Torre F.Salimei PS. J. Med. Chem. 2006, 49: 5840 -
8b
Lebegue N.Gallet S.Flouquet N.Carato P.Pfeiffer B.Renard P.Leonce S.Pierre A.Chavatte P.Berthelot P. J. Med. Chem. 2005, 48: 7363 - 9
Wroblewski T.Graul A.Castaner J. Drugs Future 1998, 23: 365 - 10
Rabasseda X.Hopkins SJ. Drugs Today 1994, 30: 557 - 11
Inagaki M.Tsuri T.Jyoyama H.Ono T.Yamada K.Kobayashi M.Hori Y.Arimura A.Yasui K.Ohno K.Kakudo S.Koizumi K.Suzuki R.Kato M.Kawai S.Matsumoto S. J. Med. Chem. 2000, 43: 2040 - 12
McKerrecher D,Pike KG, andWaring MJ. inventors; WO 2006125972. - 13
Brzozowski Z.Saczewski F.Neamati N. Bioorg. Med. Chem. Lett. 2006, 16: 5298 -
14a
Bravo RD.Canepa AS. Synth. Commun. 2002, 32: 3675 -
14b
Orazi OO.Corral RA.Bravo R. J. Heterocycl. Chem. 1986, 23: 1701 -
14c
Katritzky AR.Wu J.Rachwal S.Rachwal B.Macomber DW.Smith TP. Org. Prep. Proced. Int. 1992, 24: 463 - 15
Lee J.Zhong Y.-L.Reamer RA.Askin D. Org. Lett. 2003, 5: 4175 - 16
Enders D.Moll A.Bats JW. Eur. J. Org. Chem. 2006, 1271 - 17
Chiacchio U.Corsaro A.Rescifina A.Bkaithan M.Grassi G.Piperno A. Tetrahedron 2001, 57: 3425 -
18a
Metz P.Seng D.Frohlich R. Synlett 1996, 741 -
18b
Plietker B.Seng D.Frohlich R.Metz P. Tetrahedron 2000, 56: 873 -
18c
G reig IR.Trozer MJ.Wright PT. Org. Lett. 2001, 3: 369 - 19
Zhou A.Hanson PR. Org Lett. 2008, 10: 2951 - 20
Liu X.-Y.Li C.-H.Che C.-M. Org. Lett. 2006, 8: 2707 -
21a
Dauban P.Dodd RH. Org. Lett. 2000, 2: 2327 -
21b
Dauban P.Saniere L.Aurelie T.Dodd RH. J. Am. Chem. Soc. 2001, 123: 7707 -
21c
Sherman ES.Chemler SR.Tan TB.Gerlits O. Org. Lett. 2004, 6: 1573 -
22a
Liang J.-L.Yuan S.-X.Chan PWH.Che C.-M. Org. Lett. 2002, 4: 4507 -
22b
Padwa A.Flick AC.Leverett CA.Stengel T. J. Org. Chem. 2004, 69: 6377 -
22c
Hopkins MJ.Hanson PR. Org. Lett. 2008, 10: 2223 - 23
Hanson PR.Probst DA.Robinson RE.Yau M. Tetrahedron Lett. 1999, 40: 4761 -
24a
Merten S.Frohlich R.Kataeva O. Adv. Synth. Catal. 2005, 347: 754 -
24b
Vasudevan A.Tseng P.-S.Djuric SW. Tetrahedron Lett. 2006, 47: 8591 -
25a
Majumdar KC.Chakravorty S.De N. Tetrahedron Lett. 2008, 49: 3419 -
25b
Majumdar KC.Chattopadhaya B.Ray K. Tetrahedron Lett. 2007, 48: 7633 -
25c
Majumdar KC.Chattopadhaya B.Nath S. Tetrahedron Lett. 2008, 49: 1609 -
26a
Majumdar KC.Mondal S. Tetrahedron Lett. 2007, 48: 6951 -
26b
Majumdar KC.Mondal S. Tetrahedron Lett. 2008, 49: 2418 - 27
Reilly TP.Ju C. Curr. Opin. Allergy Clin. Immunol. 2002, 2: 307 - 29
Jeffery T. J. Chem. Soc., Chem. Commun. 1984, 1287 - 32
Beletskaya IP.Cheprakov AV. Chem. Rev. 2000, 100: 3009
References and Notes
Compound 3a: white solid, mp 133-134 ˚C; yield 95%. IR (KBr): 1342, 1160 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 2.45 (s, 3 H), 4.50 (s, 4 H,), 6.99 (t, 2 H, J = 7.8 Hz), 7.13 (t, 2 H, J = 8.4 Hz), 7.33 (t, 6 H, J = 8.4 Hz), 7.73 (d, 2 H, J = 8.2 Hz). ¹³C NMR (75 MHz, CDCl3): δ = 21.4, 52.2, 123.2, 127.1, 127.2, 128.8, 129.7, 130.0, 132.4, 134.7, 136.4, 143.5. HRMS: m/z calcd for C21H19Br2NO2S: 529.9335 [M + Na], 531.9381 [M + 2 + Na], 533.9339 [M + 4 + Na]; found: 529.9401 [M + Na], 531.9401 [M + 2 + Na], 533.9401 [M + 4 + Na].
30
General Procedure
for the Synthesis of Compounds 7a-f by the Intramolecular
Coupling Reaction
A mixture of 3a (200
mg, 0.39 mmol), TBAB (153 mg, 0.47 mmol), and dry KOAc (106 mg,
1.08 mmol) was taken up in anhyd DMF (5 mL) under a nitrogen atmosphere.
Palladium acetate (9 mg, 0.039 mmol) was added, and the reaction mixture
was stirred at 120 ˚C for 10 h. The reaction mixture was
cooled and H2O (25 mL) was added. The aqueous layer was
extracted with EtOAc (3 × 30 mL), and the organic layer was
washed with H2O (2 × 40 mL) followed by brine
(30 mL). The organic layer was dried (Na2SO4),
and the solvent was removed in vacuo. The crude product was purified
by silica gel column chromatography using EtOAc-PE (1:9)
to afford the product 7a. The other substrates 3b-f were similarly treated to
give products 7b-f.
Compound 7a: white solid, mp 241-242 ˚C;
yield 85%. IR (KBr): 1462, 1317, 1149 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 2.52 (s,
3 H), 3.86 (d, 1 H, J = 15.1
Hz), 4.11-4.19 (q, 2 H, J = 11.8
Hz), 4.45 (d, 1 H, J = 15.1
Hz), 7.34-7.37 (m, 1 H), 7.39-7.44 (m,
2 H), 7.49-7.54 (m, 3 H), 7.57-7.62 (m, 3 H),
8.25 (d, 1 H, J = 8.2
Hz). ¹³C NMR (75 MHz, CDCl3): δ = 21.5,
48.6, 49.2, 127.3, 127.4, 127.6, 128.5, 128.8, 129.0, 129.2, 129.7,
130.9, 133.7, 134.6, 136.2, 137.5, 139.5, 141.2, 144.9. HRMS: m/z calcd for C21H17NO2S: 370.0878 [M + Na];
found: 370.0878 [M + Na].
The CCDC reference number for the CIF file of compound 7a: CCDC-693638.